NADPH

Unknown Manufacturer

Generate AI report

Technical identifiers

Chemical Formula: C₂₁H₃₀N₇O₁₇P₃
CAS Number: 53-57-6
UNII ID: 381Q4X082D

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Cytochrome P450 monooxygenase CYP52A2B from Candida tropicalis
US 7049112 B2Applicant: COGNIS CORPPriority: 2001
US
11 publications
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
- EP 2166010 A1
  Applicant: GENKYO TEX SAPriority: 2008
  CN
  EP
  US
  9 publications
- EP 2002835 A1
  Applicant: GENKYO TEXPriority: 2007
  CN
  EP
  US
  6 publications
- US 8455485 B2
  Applicant: PAGE PATRICKPriority: 2008
  CN
  EP
  US
  6 publications
- US 8455486 B2
  Applicant: PAGE PATRICKPriority: 2008
  EP
  US
  5 publications
- US 8481562 B2
  Applicant: PAGE PATRICKPriority: 2008
  EP
  US
  5 publications
Means and methods of using a NADPH oxidase inhibitor for the treatment of hearing loss and phantom hearing
US 8088359 B2Applicant: KRAUSE KARL-HEINZPriority: 2004
EP
US
7 publications
Compounds as NADPH oxidase inhibitors
US 12202816 B2Applicant: CALLIDITAS THERAPEUTICS SUISSE SAPriority: 2018
CN
EP
US
WO
6 publications
NOVEL THIOHYDANTOIN DERIVATIVES AND USES THEREOF
EP 4205740 C0Applicant: CELROS BIOTECHPriority: 2020
CN
EP
US
WO
5 publications
AN ISOLATED PHYCOBILIN FOR USE IN A METHOD FOR PROPHYLAXIS OR TREATMENT OF A MEDICAL CONDITION
EP 3597188 A1Applicant: PCB ASS INCPriority: 2006
CN
EP
US
5 publications
SYNERGISTIC ACTIVITY OF MODULATORS OF THE NO METABOLISM AND OF NADPH OXIDASE IN THE SENSITIZATION OF TUMOR CELLS
US 2013171104 A1Applicant: BAUER GEORGPriority: 2010
EP
US
WO
5 publications
HYALURONIC ACID NANOPARTICLES COMPRISING NADPH OXIDASES INHIBITORS AND USES IN TREATING CANCER
EP 3946297 A4Applicant: UNIV EMORYPriority: 2019
EP
US
WO
5 publications
Autoimmune conditions and NADPH oxidase defects
- US 7294652 B2
  Applicant: AREXIS ABPriority: 2003
  US
  5 publications
- CN 101404985 A
  Applicant: BIOVITRUM AB PUBLPriority: 2006
  CN
- US 2008051451 A1
  Applicant: LINSCHOTEN MARCELPriority: 2007
  US
Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
- US 8748456 B2
  Applicant: PAGE PATRICKPriority: 2010
  CN
  EP
  US
  4 publications
- US 8865758 B2
  Applicant: PAGE PATRICKPriority: 2010
  CN
  EP
  US
  4 publications

Drugs

NADPH

Patents

Pyrazolo pyridine derivatives as NADPH oxidase inhibitors

Autoimmune conditions and NADPH oxidase defects

Pyrazolo piperidine derivatives as NADPH oxidase inhibitors